Posted inNews and Updates
ArkBio’s AK0406 Influenza Drug Enters Clinical Trials
ArkBio has launched clinical trials for its new influenza drug, AK0406. Learn how this antiviral candidate could impact future respiratory infection care.
Posted inNews and Updates
Atea Reports Success in Phase 3 Hepatitis C Clinical Trial
Atea Pharmaceuticals' bemnifosbuvir and ruzasvir combo succeeds in Phase 3 HCV trials, showing high SVR12 rates and strong potential for future approval.
Posted inNews and Updates
AI Integration Slashes Clinical Trial Costs Significantly
Discover how AI is revolutionizing clinical trials by slashing costs, optimizing patient recruitment, and accelerating the drug development pipeline.
Posted inNews and Updates
FDA Psychedelic Drug Guidelines: Impact on Future Research
Discover how the FDA’s new regulatory guidelines are shaping the future of psychedelic drug development and clinical research standards.
Posted inNews and Updates
Barriers to Clinical Trial Access for Minority Children
Financial burdens and clinician gatekeeping are limiting clinical trial access for Black and Hispanic children. Discover how to improve research equity.
Posted inNews and Updates
WHO Advances Clinical Trials for Ebola Vaccine in DRC
The WHO is advancing plans for new Ebola vaccine trials in the DRC. Discover how this move aims to improve outbreak response and global health security.
Posted inNews and Updates
Longeveron Q2 Results: Higher Trial Costs Impact Earnings
Longeveron reports a widened Q2 net loss driven by rising clinical trial and legal costs. Discover how these investments impact the firm's biotech pipeline.
Posted inNews and Updates
Ochsner Health Integrates AI to Boost Clinical Trial Access
Ochsner Health is scaling clinical trial recruitment using AI to match patients with research faster, enhancing diversity and medical innovation.
Posted inNews and Updates
Gender Disparity Persists in Structural Heart Trials
New data from the ACC reveals a persistent leadership gap in structural heart trials, threatening research inclusivity and future clinical outcomes.
Posted inNews and Updates
AI Clinical Monitoring Boosts Oncology ROI by 82x
New reports indicate AI clinical monitoring in oncology can deliver 82x ROI by streamlining trial data and reducing costly operational inefficiencies.